Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease

Clinical and Experimental Immunology

Volumn 120, Issue 2, 2000, Pages 241-246

  Louis, E ^a   Ribbens, C ^a   Godon, A ^a   Franchimont, D ^a   De Groote, D ^a   Hardy, N ^a   Boniver, J ^a   Belaiche, J ^a   Malaise, M ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

IL 10; Inflammatory bowel disease; Matrix metalloproteinase 3; Proinflammatory cytokines; Tissue inhibitor of metalloproteinase 1

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; AZATHIOPRINE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; STEROID; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; COLON; COLONOSCOPY; CROHN DISEASE; CULTURE TECHNIQUES; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; INTESTINAL MUCOSA; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034075936     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01227.x     Document Type: Article

References (29)

1. 1 Desreumaux P, Brandt E, Gambiez L et al. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology 1997; 113:118-26.
2. 2 Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiocchi C, Strober W. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. J Immunol 1996; 157:1261-70.
3. 3 Reimund JM, Wittersheim C, Dumont S, Muller CD, Kennet JS, Baumann R, Poindron P, Duclos B. Increased production of tumor necrosis factor-α, interleukin-1β. and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 1996; 39:684-9.
4. 4 Reinecker H-C, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, Raedler A. Enhanced secretion of tumour necrosis factor-alpha, IL-6 and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993; 94:174-81.
5. 5 Stevens C, Wlaz G, Singaram C et al. Tumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992; 37:818-26.
6. 6 Nielsen OH, Koppen T, Rüdiger N, Horn T, Eriksen J, Kirman I. Involvement of interleukin-4 and -10 in inflammatory bowel disease. Dig Dis Sci 1996; 41:1786-93.
7. 7 Schmit A, Van Gossum A, Carol M, Mascart-Lemone F. Different cytokine patterns within inflamed and non inflamed colonic mucosa in Crohn's disease. Gastroenterology 1998; 114:G4417(Abstr.).
8. 8 Kucharzik T, Stoll R, Lügering N, Domschke W. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 100:452-6.
9. 9 Schreiber S, Heinig T, Thiele HG, Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995; 108:1434-44.
10. 10 Kusano K, Miyaura C, Inada M, Tamura T, Ito A, Nagase H, Kamoi K, Suda T. Regulation of matrix metalloproteinases (MMP-2-3-9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 1998; 139:1338-45.
11. 11 Saren P, Welgus HG, Kovanen PT. TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996; 157:4159-65.
12. 12 Murphy G, Reynolds JJ, Werb Z. Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-o-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. J Biol Chem 1985; 260:3079-83.
13. 13 Lotz M, Guerne P-A. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 1991; 266:2017-20.
14. 14 Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer J-M. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 1995; 96:2304-10.
15. 15 Pender SLF, Breese EJ, Günther U, Howie D, Wathen NC, Schuppan D, McDonald TT. Suppression of cell-mediated injury in human gut by interleukin 10: role of matrix metalloproteinases. Gastroenterology 1998; 115:573-83.
16. 16 Reitamo S, Remitz A, Tamai K, Uitto J. Interleukin-10 modulates type 1 collagen and matrix metalloproteinase gene expression in cultured human skin fibroblasts. J Clin Invest 1994; 94:2489-92.
17. 17 Stetler-Stevenson W. Type IV collagenase in tumour invasion and metastasis. Cancer Metastasis Rev 1990; 9:289-303.
18. 18 Bailey CJ, Hembry RM, Alexander A, Irving MH, Grant ME, Shuttleworth CA. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. J Clin Pathol 1994; 47:113-6.
19. 19 Saarialho-Kere UK, Vaalmo M, Puolakkainen P, Airola K, Parks WC, Karjalainen-Lindsberg M-L. Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am J Pathol 1996; 148:519-26.
20. 20 Pender SLF, Tickle SP, Docherty AJP, Howie D, Wathen NC, McDonald TT. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 1997; 158:1582-90.
21. 21 Pender SLF, Fell JME, Chamow SM, Ashkenazi A, McDonald TT. A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production. J Immunol 1998; 160:4098-103.
22. 22 Albin RJ, Senior RM, Welgus HG, Connoly NL, Campbell EJ. Human alveolar macrophages release an inhibitor of metalloproteinase elastase in vitro. Am Rev Respir Dis 1987; 135:1281-5.
23. 23 Howard EW, Bullen EC, Banda MJ. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinase-2. J Biol Chem 1991; 266:13064-9.
24. 24 Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 1979; 77:843-6.
25. 25 Wardle TD, Hall L, Turnberg LA. Use of coculture of colonic biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease. Gut 1992; 33:1644-51.
26. 26 Riley SA, Mani V, Goodman MJ, Dutt S, Herd ME. Microscopic activity in ulcerative colitis: what does it mean ? Gut 1991; 32:174-8.
27. 27 Autsbach F, Braunstein J, Helmke B et al. In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease. Am J Pathol 1998; 153:121-30.
28. 28 Ito A, Ito Y, Sasaguri Y, Norimatsu M, Mori Y. Effects of interleukin6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts. Arthritis Rheum 1992; 35:1197-201.
29. 29 Baugh MD, Perry MJ, Hollander AP, Davies DR, Cross SS, Lobo AJ, Taylor CJ, Evans GS. Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 1999; 117:814-22.